Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Friesen

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Quinolines as potent 5-lipoxygenase inhibitors: synthesis and biological profile of L-746,530D Dubé, M Blouin, C Brideau, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
2,3-Diarylthiophenes as selective EP1 receptor antagonistsYves Ducharme, Marc Blouin, Marie-Claude Carrière, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2006
Substituted coumarins as potent 5-lipoxygenase inhibitorsErich L Grimm, Christine Brideau, Nathalie Chauret, et al.
Bioorganic & Medicinal Chemistry Letters|January 11, 2011
Naphthalene/quinoline amides and sulfonylureas as potent and selective antagonists of the EP4 receptorJason D Burch, Julie Farand, John Colucci, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2007
Substituted phenanthrene imidazoles as potent, selective, and orally active mPGES-1 inhibitorsBernard Côté, Louise Boulet, Christine Brideau, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2011
Trisubstituted ureas as potent and selective mPGES-1 inhibitorsJean-François Chiasson, Louise Boulet, Christine Brideau, et al.
Bioorganic & Medicinal Chemistry Letters|September 15, 2009
Discovery of disubstituted phenanthrene imidazoles as potent, selective and orally active mPGES-1 inhibitorsAndré Giroux, Louise Boulet, Christine Brideau, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
2-Pyridinyl-3-(4-methylsulfonyl)phenylpyridines: selective and orally active cyclooxygenase-2 inhibitorsR W Friesen, C Brideau, C C Chan, et al.
Bioorganic & Medicinal Chemistry Letters|October 12, 2010
Discovery of MK-0952, a selective PDE4 inhibitor for the treatment of long-term memory loss and mild cognitive impairmentMichel Gallant, Renee Aspiotis, Stephen Day, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 13, 2001
Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2D Riendeau, M D Percival, C Brideau, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Quinolines as potent 5-lipoxygenase inhibitors: synthesis and biological profile of L-746,530D Dubé, M Blouin, C Brideau, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
2,3-Diarylthiophenes as selective EP1 receptor antagonistsYves Ducharme, Marc Blouin, Marie-Claude Carrière, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2006
Substituted coumarins as potent 5-lipoxygenase inhibitorsErich L Grimm, Christine Brideau, Nathalie Chauret, et al.
Bioorganic & Medicinal Chemistry Letters|January 11, 2011
Naphthalene/quinoline amides and sulfonylureas as potent and selective antagonists of the EP4 receptorJason D Burch, Julie Farand, John Colucci, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2007
Substituted phenanthrene imidazoles as potent, selective, and orally active mPGES-1 inhibitorsBernard Côté, Louise Boulet, Christine Brideau, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2011
Trisubstituted ureas as potent and selective mPGES-1 inhibitorsJean-François Chiasson, Louise Boulet, Christine Brideau, et al.
Bioorganic & Medicinal Chemistry Letters|September 15, 2009
Discovery of disubstituted phenanthrene imidazoles as potent, selective and orally active mPGES-1 inhibitorsAndré Giroux, Louise Boulet, Christine Brideau, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
2-Pyridinyl-3-(4-methylsulfonyl)phenylpyridines: selective and orally active cyclooxygenase-2 inhibitorsR W Friesen, C Brideau, C C Chan, et al.
Bioorganic & Medicinal Chemistry Letters|October 12, 2010
Discovery of MK-0952, a selective PDE4 inhibitor for the treatment of long-term memory loss and mild cognitive impairmentMichel Gallant, Renee Aspiotis, Stephen Day, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 13, 2001
Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2D Riendeau, M D Percival, C Brideau, et al.
Pageof 6